Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study

E. Hertle; M.M.J. van Greevenbroek; I.C.W. Arts; C.J.H. van der Kallen; E.J.M. Feskens; C.G. Schalkwijk; C.D.A. Stehouwer

doi:10.1016/j.ijcard.2014.04.057

Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study

E. Hertle^*
, M.M.J. van Greevenbroek
, I.C.W. Arts
, C.J.H. van der Kallen
, E.J.M. Feskens
, C.G. Schalkwijk
, C.D.A. Stehouwer

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	400-403
Number of pages	4
Journal	International Journal of Cardiology
Volume	174
Issue number	2
DOIs	https://doi.org/10.1016/j.ijcard.2014.04.057
Publication status	Published - 1 Jan 2014

Access to Document

10.1016/j.ijcard.2014.04.057

Cite this

Hertle, E., van Greevenbroek, M. M. J., Arts, I. C. W., van der Kallen, C. J. H., Feskens, E. J. M., Schalkwijk, C. G., & Stehouwer, C. D. A. (2014). Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study. International Journal of Cardiology, 174(2), 400-403. https://doi.org/10.1016/j.ijcard.2014.04.057

@article{3a71322209824f4199751bc33b09b8ce,

title = "Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study",

author = "E. Hertle and \{van Greevenbroek\}, M.M.J. and I.C.W. Arts and \{van der Kallen\}, C.J.H. and E.J.M. Feskens and C.G. Schalkwijk and C.D.A. Stehouwer",

year = "2014",

month = jan,

day = "1",

doi = "10.1016/j.ijcard.2014.04.057",

language = "English",

volume = "174",

pages = "400--403",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

Hertle, E, van Greevenbroek, MMJ , Arts, ICW , van der Kallen, CJH, Feskens, EJM, Schalkwijk, CG & Stehouwer, CDA 2014, 'Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study', International Journal of Cardiology, vol. 174, no. 2, pp. 400-403. https://doi.org/10.1016/j.ijcard.2014.04.057

Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study. / Hertle, E.; van Greevenbroek, M.M.J.; Arts, I.C.W. et al.
In: International Journal of Cardiology, Vol. 174, No. 2, 01.01.2014, p. 400-403.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study

AU - Hertle, E.

AU - van Greevenbroek, M.M.J.

AU - Arts, I.C.W.

AU - van der Kallen, C.J.H.

AU - Feskens, E.J.M.

AU - Schalkwijk, C.G.

AU - Stehouwer, C.D.A.

PY - 2014/1/1

Y1 - 2014/1/1

U2 - 10.1016/j.ijcard.2014.04.057

DO - 10.1016/j.ijcard.2014.04.057

M3 - Article

C2 - 24794956

SN - 0167-5273

VL - 174

SP - 400

EP - 403

JO - International Journal of Cardiology

JF - International Journal of Cardiology

IS - 2

ER -

Hertle E, van Greevenbroek MMJ , Arts ICW , van der Kallen CJH, Feskens EJM, Schalkwijk CG et al. Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study. International Journal of Cardiology. 2014 Jan 1;174(2):400-403. doi: 10.1016/j.ijcard.2014.04.057